Literature DB >> 33537932

A qualitative exploration of the patient experience of erosive and non-erosive hand osteoarthritis.

Charlotte Panter1, Pamela Berry2,3, Deven Chauhan4, Sofia Fernandes5, Sally Gatsi2, Josephine Park2, Jane R Wells1, Rob Arbuckle1.   

Abstract

BACKGROUND: Many patients with hand osteoarthritis (HOA) experience reduced health-related quality of life. This study sought to better understand the disease and treatment experience of individuals with HOA, explore any differences in experiences between erosive and non-erosive HOA sub-types, and evaluate content validity of the Michigan Hand Outcomes Questionnaire (MHQ) in HOA.
METHODS: Thirty subjects from the United States (n = 15 erosive HOA; n = 15 non-erosive HOA) participated in semi-structured interviews: concept elicitation explored symptoms/impacts important to patients; cognitive interviews assessed understanding and relevance of the MHQ. A sub-sample participated in real-time data capture (RTDC) activities via a smartphone/tablet app over 7 days. Verbatim transcripts were coded using Atlas.ti software and thematically analyzed. Concept saturation and MHQ content validity were evaluated.
RESULTS: Most participants reported experiencing pain, swelling and stiffness, symptoms that most commonly had a direct impact on physical functioning. Substantial impacts on activities of daily living, emotional functioning, sleep and work were also reported. RTDC findings corroborated concept elicitation findings. There were no notable differences between erosive and non-erosive HOA, except nodules were reported more frequently in erosive disease. Most participants used analgesic treatments, but effects were short-lived. Pain was the symptom most frequently reported as most bothersome and important to treat. Concept saturation was achieved. MHQ items and instructions were well understood and relevant to most participants; stiffness and swelling were reported as important symptoms not included in the MHQ.
CONCLUSIONS: This study characterizes key symptoms of HOA which are burdensome for patients and not well controlled by current therapies, highlighting an unmet treatment need. Although the study is limited by a small sample size that may not be representative of the broader erosive and non-erosive HOA population, concept saturation was achieved, and our findings suggest that disease experience is similar for patients with erosive and non-erosive HOA. Evaluation of stiffness and swelling items in conjunction with the MHQ may enhance relevance and improve measurement precision to assess important domains of HQRoL in an HOA population.

Entities:  

Keywords:  Concept elicitation; Hand osteoarthritis; Michigan Hand Outcomes Questionnaire; Patient-experience; Patient-reported outcomes; Qualitative interviews; Real-time data capture

Year:  2021        PMID: 33537932      PMCID: PMC7859145          DOI: 10.1186/s41687-021-00286-1

Source DB:  PubMed          Journal:  J Patient Rep Outcomes        ISSN: 2509-8020


  36 in total

Review 1.  Assessing and demonstrating data saturation in qualitative inquiry supporting patient-reported outcomes research.

Authors:  Cicely Kerr; Annabel Nixon; Diane Wild
Journal:  Expert Rev Pharmacoecon Outcomes Res       Date:  2010-06       Impact factor: 2.217

2.  Hand function in female patients with hand osteoarthritis: relation with radiological progression.

Authors:  Esma Ceceli; Sebahat Gül; Pınar Borman; Selma Ramadan Uysal; Müyesser Okumuş
Journal:  Hand (N Y)       Date:  2012-09

3.  Dimensionality and clinical importance of pain and disability in hand osteoarthritis: Development of the Australian/Canadian (AUSCAN) Osteoarthritis Hand Index.

Authors:  N Bellamy; J Campbell; B Haraoui; R Buchbinder; K Hobby; J H Roth; J C MacDermid
Journal:  Osteoarthritis Cartilage       Date:  2002-11       Impact factor: 6.576

Review 4.  Osteoarthritis: an update with relevance for clinical practice.

Authors:  Johannes W J Bijlsma; Francis Berenbaum; Floris P J G Lafeber
Journal:  Lancet       Date:  2011-06-18       Impact factor: 79.321

5.  Activity limitations and participation restrictions in women with hand osteoarthritis: patients' descriptions and associations between dimensions of functioning.

Authors:  I Kjeken; H Dagfinrud; B Slatkowsky-Christensen; P Mowinckel; T Uhlig; T K Kvien; A Finset
Journal:  Ann Rheum Dis       Date:  2005-04-13       Impact factor: 19.103

Review 6.  The contribution of osteoarthritis to functional limitations and disability.

Authors:  Christine M McDonough; Alan M Jette
Journal:  Clin Geriatr Med       Date:  2010-08       Impact factor: 3.076

7.  Clinical burden of erosive hand osteoarthritis and its relationship to nodes.

Authors:  J Bijsterbosch; I Watt; I Meulenbelt; F R Rosendaal; T W J Huizinga; M Kloppenburg
Journal:  Ann Rheum Dis       Date:  2010-04-21       Impact factor: 19.103

8.  Thumb base involvement in symptomatic hand osteoarthritis is associated with more pain and functional disability.

Authors:  Jessica Bijsterbosch; Willemien Visser; Herman M Kroon; Tanja Stamm; Ingrid Meulenbelt; Tom W J Huizinga; Margreet Kloppenburg
Journal:  Ann Rheum Dis       Date:  2010-02-02       Impact factor: 19.103

9.  PRO development: rigorous qualitative research as the crucial foundation.

Authors:  Kathryn Eilene Lasch; Patrick Marquis; Marc Vigneux; Linda Abetz; Benoit Arnould; Martha Bayliss; Bruce Crawford; Kathleen Rosa
Journal:  Qual Life Res       Date:  2010-05-30       Impact factor: 4.147

10.  A comparison of three methods to generate a conceptual understanding of a disease based on the patients' perspective.

Authors:  Louise Humphrey; Thomas Willgoss; Andrew Trigg; Stephanie Meysner; Mary Kane; Sally Dickinson; Helen Kitchen
Journal:  J Patient Rep Outcomes       Date:  2017-12-19
View more
  1 in total

1.  Erosive Hand OsteoArthritis (EHOA): analysis of consecutive patients presenting with EHOA in a hospital-based rheumatology practice and its implications for an upcoming interventional study.

Authors:  Tanja Giesen; Sebastian Sanduleanu; Tim L Th A Jansen
Journal:  Clin Rheumatol       Date:  2022-02-02       Impact factor: 2.980

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.